Characterization of the Visceral Antinociceptive Effect of Glial Glutamate Transporter GLT-1 Upregulation by Ceftriaxone

Overview

Journal ISRN Pain

Date 2016 Jun 24

PMID 27335870

Citations 3

Authors

K Roman

M Yang

Robert L Stephens Jr

Affiliations

Soon will be listed here.

Abstract

Recent studies demonstrate that glial glutamate transporter-1 (GLT-1) upregulation attenuates visceral nociception. The present work further characterized the effect of ceftriaxone- (CTX-) mediated GLT-1 upregulation on visceral hyperalgesia. Intrathecal pretreatment with dihydrokainate, a selective GLT-1 antagonist, produced a reversal of the antinociceptive response to bladder distension produced by CTX. The hyperalgesic response to urinary bladder distension caused by intravesicular acrolein was also attenuated by CTX treatment as was the enhanced time spent licking of abdominal area due to intravesicular acrolein. Bladder inflammation via cyclophosphamide injections enhanced the nociceptive to bladder distension; cohorts administered CTX and concomitant cyclophosphamide showed reduced hyperalgesic response. Cyclophosphamide-induced bladder hyperalgesia correlated with a significant 22% increase in GluR1 AMPA receptor subunit expression in the membrane fraction of the lumbosacral spinal cord, which was attenuated by CTX coadministration. Finally, neonatal colon insult-induced hyperalgesia caused by intracolonic mustard oil (2%) administration at P9 and P11 was attenuated by CTX. These studies suggest that GLT-1 upregulation (1) attenuates the hyperalgesia caused by bladder irritation/inflammation or by neonatal colonic insult, (2) acts at a spinal site, and (3) may produce antinociceptive effects by attenuating GluR1 membrane trafficking. These findings support further consideration of this FDA-approved drug to treat chronic pelvic pain syndromes.

Citing Articles

Impact of electro-acupuncture on EAAT2 and NMDAR-2B expression in goats with visceral hypersensitivity.

Tahir A, Ding Y, Wan J, Shah M, Janyaro H, Li X Heliyon. 2024; 10(23):e40700.

PMID: 39717594 PMC: 11665384. DOI: 10.1016/j.heliyon.2024.e40700.

Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.

Moloney R, OMahony S, Dinan T, Cryan J Front Psychiatry. 2015; 6:15.

PMID: 25762939 PMC: 4329736. DOI: 10.3389/fpsyt.2015.00015.

Optimization of a pain model: effects of body temperature and anesthesia on bladder nociception in mice.

Sadler K, Stratton J, Deberry J, Kolber B PLoS One. 2013; 8(11):e79617.

PMID: 24223980 PMC: 3818235. DOI: 10.1371/journal.pone.0079617.

References

Boudes M, Uvin P, Kerselaers S, Vennekens R, Voets T, Ridder D . Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice. Neurourol Urodyn. 2011; 30(8):1659-65. DOI: 10.1002/nau.21180. View

Choi J, Svensson C, Koehrn F, Bhuskute A, Sorkin L . Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior. Pain. 2010; 149(2):243-253. PMC: 2860679. DOI: 10.1016/j.pain.2010.02.008. View

Park J, Yaster M, Guan X, Xu J, Shih M, Guan Y . Role of spinal cord alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in complete Freund's adjuvant-induced inflammatory pain. Mol Pain. 2009; 4:67. PMC: 2628655. DOI: 10.1186/1744-8069-4-67. View

Vizzard M, Erdman S, de Groat W . Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol. 1996; 370(2):191-202. DOI: 10.1002/(SICI)1096-9861(19960624)370:2<191::AID-CNE5>3.0.CO;2-Y. View

Galan A, Cervero F, Laird J . Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. Brain Res Mol Brain Res. 2003; 116(1-2):126-34. DOI: 10.1016/s0169-328x(03)00284-5. View

Videlock E, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M . Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology. 2009; 137(6):1954-62. PMC: 2789911. DOI: 10.1053/j.gastro.2009.08.058. View

Berger U, Hediger M . Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs. Anat Embryol (Berl). 2006; 211(6):595-606. DOI: 10.1007/s00429-006-0109-x. View

Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha P . The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology. 2007; 132(2):615-27. DOI: 10.1053/j.gastro.2006.11.014. View

Elsenbruch S . Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2010; 25(3):386-94. DOI: 10.1016/j.bbi.2010.11.010. View

10.

Hartmann B, Ahmadi S, Heppenstall P, Lewin G, Schott C, Borchardt T . The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain. Neuron. 2004; 44(4):637-50. DOI: 10.1016/j.neuron.2004.10.029. View

11.

Jasmin L, Vit J, Bhargava A, Ohara P . Can satellite glial cells be therapeutic targets for pain control?. Neuron Glia Biol. 2010; 6(1):63-71. PMC: 3139431. DOI: 10.1017/S1740925X10000098. View

12.

Rothstein J, Patel S, Regan M, Haenggeli C, Huang Y, Bergles D . Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005; 433(7021):73-7. DOI: 10.1038/nature03180. View

13.

Ji R, Gereau 4th R, Malcangio M, Strichartz G . MAP kinase and pain. Brain Res Rev. 2009; 60(1):135-48. PMC: 2666786. DOI: 10.1016/j.brainresrev.2008.12.011. View

14.

Holschneider D, Bradesi S, Mayer E . The role of experimental models in developing new treatments for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2011; 5(1):43-57. PMC: 3124306. DOI: 10.1586/egh.10.88. View

15.

Bon K, Lichtensteiger C, Wilson S, Mogil J . Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences. J Urol. 2003; 170(3):1008-12. DOI: 10.1097/01.ju.0000079766.49550.94. View

16.

Hu Y, Li W, Lu L, Cai J, Xian X, Zhang M . An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain. 2009; 148(2):284-301. DOI: 10.1016/j.pain.2009.11.014. View

17.

Katano T, Furue H, Okuda-Ashitaka E, Tagaya M, Watanabe M, Yoshimura M . N-ethylmaleimide-sensitive fusion protein (NSF) is involved in central sensitization in the spinal cord through GluR2 subunit composition switch after inflammation. Eur J Neurosci. 2008; 27(12):3161-70. DOI: 10.1111/j.1460-9568.2008.06293.x. View

18.

Zhou R, Holmes A, Du J, Malkesman O, Yuan P, Wang Y . Genome-wide gene expression profiling in GluR1 knockout mice: key role of the calcium signaling pathway in glutamatergically mediated hippocampal transmission. Eur J Neurosci. 2010; 30(12):2318-26. PMC: 3035979. DOI: 10.1111/j.1460-9568.2009.07022.x. View

19.

Larauche M, Mulak A, Tache Y . Stress and visceral pain: from animal models to clinical therapies. Exp Neurol. 2011; 233(1):49-67. PMC: 3224675. DOI: 10.1016/j.expneurol.2011.04.020. View

20.

Rasmussen B, Baron D, Kim J, Unterwald E, Rawls S . β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids. 2010; 40(2):761-4. PMC: 2988910. DOI: 10.1007/s00726-010-0589-0. View